(S1 (S (NP (NP (JJ M-CSF-Dependent) (NN Activation)) (PP (IN of) (NP (NN PKC))) (VP (VBZ Does) (RB Not) (VP (VB Regulate) (NP (DT the) (JJ Classical) (NN NF-kappaB) (NN p65) (NN Activation) (NN Pathway)))))))
(S1 (S (NP (NP (JJ Canonical) (NN activation)) (PP (IN of) (NP (NN NF-kappaB)))) (VP (VBZ occurs) (PP (IN via) (NP (NP (NP (NP (NP (NN phosphorylation)) (CC and) (NP (NN degradation))) (PP (IN of) (NP (NP (NN IkappaBalpha)) (VP (VBG leading) (PP (TO to) (NP (DT the) (NN release))))))) (CC and) (NP (JJ nuclear) (NN translocation))) (PP (IN of) (NP (DT the) (NN NF-kappaB) (NN p50/p65) (NN heterodimer))) (S (VP (TO to) (VP (VB transactivate) (NP (NN target) (NNS genes)) (PRN (-LRB- -LSB-) (NP (CD 37)) (-RRB- -RSB-))))) (, ,))) (PRN (-LRB- -LSB-) (NP (CD 39)) (-RRB- -RSB-))) (. .)))
(S1 (S (S (SBAR (IN Since) (S (NP (JJ conventional) (NN PKC) (NN activity)) (VP (VBD was) (ADJP (JJ important)) (PP (IN in) (S (VP (VBG regulating) (NP (JJ M-CSF-induced) (NN NF-kappaB) (NN activation)))))))) (, ,) (NP (PRP we)) (ADVP (RB next)) (VP (VBD investigated) (SBAR (IN whether) (S (NP (NN IkappaBalpha) (NN degradation)) (VP (VBD was) (VP (VBN regulated) (PP (IN by) (NP (NN PKC))))))))) (. .)))
(S1 (S (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NN cyclohexamide)) (PRN (-LRB- -LRB-) (NP (NN CHX)) (-RRB- -RRB-)))) (S (VP (TO to) (VP (VB inhibit) (NP (NP (NN protein) (NN synthesis)) (PP (IN of) (NP (NN IkappaBalpha)))))))))) (, ,) (CC and) (S (NP (PRP$ its) (NN degradation)) (VP (VBD was) (VP (VBN followed))))) (. .)))
(S1 (S (S (SBAR (IN As) (S (VP (VBN shown) (PP (IN in) (NP (NN Figure) (NN 5A)))))) (, ,) (NP (NP (NN PKC) (NN inhibition)) (PP (IN with) (NP (NN Ro-31-8220)))) (VP (VBD did) (RB not) (VP (VB alter) (NP (JJ M-CSF-induced) (NN IkappaBalpha) (NN degradation)) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (JJ M-CSF-induced) (NN PKC) (NN activity)) (VP (VBD augmented) (NP (NN NF-kappaB) (JJ transcriptional) (NN activity)) (PP (IN by) (NP (DT an) (JJ alternative) (NN pathway))) (, ,) (PP (IN like) (NP (NP (JJ post-translational) (NN modification)) (PP (IN of) (NP (NN NF-kappaB) (NN p65))))))))))))) (. .)))
